|
1. Impairment of self-esteem
|
.55**
|
.26**
|
.20**
|
−.08
|
−.07
|
.01
|
.11
|
.04
|
−.04
|
.08
|
.09
|
−.56**
|
|
2. Changes in erectile functioning
|
–
| | | | | | | | | | | |
|
3. Importance of sexuality
|
.23**
|
–
| | | | | | | | | | |
|
4. Importance* changes EF
|
−.12
|
−.14*
|
–
| | | | | | | | | |
|
5. Age
|
−.16**
|
−.34**
|
.19**
|
–
| | | | | | | | |
|
6. Living with partner
|
.04
|
.13*
|
−.05
|
−.03
|
–
| | | | | | | |
|
7. Higher education
|
.58
|
.03
|
−.04
|
−.03
|
.10
|
–
| | | | | | |
|
8. Still working
|
.09
|
.23**
|
<−.01
|
−.59**
|
.08
|
.06
|
–
| | | | | |
|
9. Time since treatment decision
|
−.01
|
−.01
|
.03
|
.21**
|
−.08
|
.06
|
−.13*
|
–
| | | | |
|
10. Gleason-Score (low)
|
−.27**
|
−.13*
|
.04
|
.09
|
.01
|
−.01
|
−.03
|
.02
|
–
| | | |
|
11. PSA
|
.17**
|
<.01
|
−.04
|
.06
|
−.07
|
−.02
|
−.10
|
−.03
|
−.13*
|
–
| | |
|
12. Number of comorbidities
|
.11
|
−.07
|
.01
|
.07
|
−.04
|
−.05
|
<.01
|
.05
|
−.04
|
−.11
|
–
| |
|
13. Satisfaction with sexual life
|
−.42**
|
−.09
|
−.20**
|
−.01
|
−.01
|
.01
|
−.01
|
.04
|
.04
|
−.16**
|
−.06
|
–
|
